Celsion Corporation Share Price Nasdaq
Equities
US15117N4043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
20/05 | Imunon, Inc. Announces CFO Changes, Effective from June 1, 2024 | CI |
13/05 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.25Cr 104.25Cr |
---|---|---|---|---|---|
Net income 2024 * | -2.1Cr -175.09Cr | Net income 2025 * | -2.5Cr -208.44Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.81
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Celsion Corporation
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 04/21/04 |
Michael Tardugno
CHM | Chairman | 73 | 03/07/03 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 11/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 08/21/08 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08/11/08 |
James Dentzer
BRD | Director/Board Member | 57 | 03/22/03 |
1st Jan change | Capi. | |
---|---|---|
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.4TCr | |
+2.18% | 2.26TCr | |
-10.09% | 1.82TCr | |
-40.52% | 1.68TCr | |
-14.00% | 1.62TCr | |
+1.18% | 1.34TCr | |
+24.18% | 1.13TCr |